BioSpace News Archive

Today, the Food and Drug Administration (FDA) granted accelerated approval of a first of its kind drug therapy, resmetirom, for the treatment of nonalcoholic steatohepatitis (NASH) in patients who have progressed to fibrosis.

SkinCure Oncology presented to dermatology patients as the GentleCure™ Experience, notes that actress Christie Brinkley says she was diagnosed with a common form of skin cancer and her doctor “stitched me up to perfection,” but, the company underscores, most of the 9,100 Americans who are diagnosed with nonmelanoma skin cancer every day can cure their cancer without surgery.

Movano Health (Nasdaq: MOVE) has completed another hypoxia trial with the University of California, San Francisco (UCSF) yielding new blood oxygen saturation (SpO2) data, confirming the accuracy of its Evie Ring pulse oximeter exceeds the U.S. Food and Drug Administration (FDA) guidelines.

Bristol Myers Squibb (NYSE: BMY) today announced the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Breyanzi®.

Biotheus Inc. and Hansoh Pharmaceutical Group Co., Ltd., China’s leading innovation-driven pharmaceutical company, jointly announced that the two parties will further expand their strategic collaboration, following their current partnership since 2022.